$XLRN ACCELERON PHARMA INC Insider Trading Week 37/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC in week 37/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 34.96 | 400 | 13,984 | 9,700 | 10.1 K to 9.7 K (-3.96 %) |
Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 34.93 | 200 | 6,986 | 96,404 | 96.6 K to 96.4 K (-0.21 %) |
Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 33.55 | 300 | 10,065 | 96,604 | 96.9 K to 96.6 K (-0.31 %) |
Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 32.22 | 1,100 | 35,442 | 96,904 | 98 K to 96.9 K (-1.12 %) |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 2,000 | 10,560 | 32,307 | |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 33.61 | 2,000 | 67,220 | 119,656 | 121.7 K to 119.7 K (-1.64 %) |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 2,000 | 10,560 | 121,656 | 119.7 K to 121.7 K (+1.67 %) |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 3.88 | 11,485 | 44,562 | 13,515 | |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 35.00 | 33,000 | 1,155,000 | 56,685 | 89.7 K to 56.7 K (-36.80 %) |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 3.88 | 11,485 | 44,562 | 89,685 | 78.2 K to 89.7 K (+14.69 %) |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 3.88 | 5,500 | 21,340 | 22,000 | |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 34.17 | 1,400 | 47,838 | 76,123 | 77.5 K to 76.1 K (-1.81 %) |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 33.07 | 4,100 | 135,587 | 77,523 | 81.6 K to 77.5 K (-5.02 %) |
Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 3.88 | 5,500 | 21,340 | 81,623 | 76.1 K to 81.6 K (+7.23 %) |
Sep 15 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 0.40 | 8,500 | 3,400 | 0 | |
Sep 15 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 0.40 | 8,500 | 3,400 | 119,084 | 110.6 K to 119.1 K (+7.69 %) |